Q3 2026 13F filing
Updated 6 days ago74 disclosed positions worth $6.1B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GUARDANT HEALTH INC | $500.4M | 2.81M | 8.15% | — |
| 2 | B BIOMARIN PHARMACEUTICAL INC | $382.5M | 6.37M | 6.23% | — |
| 3 | I IMMUNOVANT INC | $309.5M | 9.16M | 5.04% | — |
| 4 | T TARSUS PHARMACEUTICALS INC | $299.3M | 3.81M | 4.87% | — |
| 5 | M VERADERMICS INC | $230.3M | 1.90M | 3.75% | — |
| 6 | V VERA THERAPEUTICS INC | $226M | 7.00M | 3.68% | — |
| 7 | P VAXCYTE INC | $199.9M | 3.51M | 3.26% | — |
| 8 | A ALKERMES PLC | $182.3M | 4.50M | 2.97% | — |
| 9 | O OCULAR THERAPEUTIX INC | $168.3M | 21.94M | 2.74% | — |
| 10 | U UNITED THERAPEUTICS CORP DEL | $162.6M | 300.0K | 2.65% | — |
| 11 | G STRUCTURE THERAPEUTICS INC | $156.3M | 5.00M | 2.55% | — |
| 12 | G GRAIL INC | $154.7M | 1.10M | 2.52% | — |
| 13 | I INSMED INC | $154.1M | 1.35M | 2.51% | — |
| 14 | C COMPASS PATHWAYS PLC | $151.3M | 12.16M | 2.46% | — |
| 15 | G GENMAB A/S | $149.2M | 4.18M | 2.43% | — |
| 16 | A AXSOME THERAPEUTICS INC. | $147.5M | 800.0K | 2.40% | — |
| 17 | N NURIX THERAPEUTICS INC | $142.3M | 6.00M | 2.32% | — |
| 18 | L LB PHARMACEUTICALS INC | $128.7M | 3.35M | 2.10% | — |
| 19 | T TANGO THERAPEUTICS INC | $112.3M | 4.50M | 1.83% | — |
| 20 | M MAZE THERAPEUTICS INC | $111M | 4.08M | 1.81% | — |
| 21 | C HEMAB THERAPEUTICS HLDGS INC | $110.6M | 3.59M | 1.80% | — |
| 22 | G GENMAB A/S | $98.5M | 2.76M | 1.60% | — |
| 23 | M MOONLAKE IMMUNOTHERAPEUTICS | $94.8M | 8.11M | 1.54% | — |
| 24 | O ORUKA THERAPEUTICS INC | $89.1M | 1.07M | 1.45% | — |
| 25 | W GENEDX HOLDINGS CORP | $86.8M | 1.20M | 1.41% | — |
| 26 | T TEMPUS AI INC | $81.9M | 1.00M | 1.33% | — |
| 27 | C COGENT BIOSCIENCES INC | $80M | 2.50M | 1.30% | — |
| 28 | G GH RESEARCH PLC | $78.3M | 3.33M | 1.27% | — |
| 29 | B BICARA THERAPEUTICS INC | $76.3M | 4.10M | 1.24% | — |
| 30 | L LATIGO BIOTHERAPEUTICS INC | $73.6M | 4.41M | 1.20% | — |
| 31 | C CELLDEX THERAPEUTICS INC NEW | $68.9M | 2.13M | 1.12% | — |
| 32 | B BRIDGEBIO PHARMA INC | $58.3M | 885.9K | 0.95% | — |
| 33 | A AVALO THERAPEUTICS INC | $55.3M | 3.61M | 0.90% | — |
| 34 | A ALUMIS INC | $55.2M | 7.47M | 0.90% | — |
| 35 | ? N/A ALTIMMUNE INC | $55.1M | 19.25M | 0.90% | — |
| 36 | ? N/A ATTOVIA THERAPEUTICS INC | $55M | 3.21M | 0.90% | — |
| 37 | B BILLIONTOONE INC | $53.2M | 500.0K | 0.87% | — |
| 38 | A ACLARIS THERAPEUTICS INC | $49.2M | 9.35M | 0.80% | — |
| 39 | C CORMEDIX INC | $48.3M | 6.27M | 0.79% | — |
| 40 | E EDGEWISE THERAPEUTICS INC | $46.6M | 1.15M | 0.76% | — |
| 41 | V VERASTEM INC | $46.2M | 5.74M | 0.75% | — |
| 42 | D DEFINIUM THERAPEUTICS INC | $38.1M | 1.00M | 0.62% | — |
| 43 | G GENERATE BIOMEDICINES INC | $37.7M | 2.51M | 0.61% | — |
| 44 | M MBX BIOSCIENCES INC | $37.5M | 640.0K | 0.61% | — |
| 45 | A ANI PHARMACEUTICALS INC | $36.3M | 500.0K | 0.59% | — |
| 46 | V VIRIDIAN THERAPEUTICS INC | $35.2M | 1.71M | 0.57% | — |
| 47 | H HARROW INC | $32.9M | 1.07M | 0.54% | — |
| 48 | O OBSIDIAN THERAPEUTICS INC | $29.1M | 2.12M | 0.47% | — |
| 49 | C CORVUS PHARMACEUTICALS INC | $28.7M | 2.49M | 0.47% | — |
| 50 | N NEUROCRINE BIOSCIENCES INC | $28.4M | 200.0K | 0.46% | — |